Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

Heart failure is responsible for 13 percent of deaths worldwide, and half of patients die within 5 years. New therapies are ...

New device receives Health Canada approval after LHSC team participates in global study to prove safety and efficacy ...

In this prospective study, the use of a leadless pacemaker that received wireless communication from a subcutaneous ...

Severe temperature spikes may double or triple the risk of irregular heart rhythm in people with implanted defibrillators. An analysis of health data for more than 2,000 people with implantable ...

The implantable cardioverter-defibrillator (ICD) detects and terminates these arrhythmias. However, defibrillator therapy is limited by the profound difficulty to identify patients at elevated ...

Implantable cardiac devices play a significant role in decreasing the morbidity and mortality in patients with cardiovascular disease. Tissue-device interactions leading to systemic ...